Alfresa Holdings Corporation

ARHCFOTCHealthcare● Active

$11.87

+$0.00(+0.00%)

Market Cap$2.2B

P/E Ratio—

52W High$11.87

52W Low$11.87

Avg Volume411.76471

Open$11.87

Beta-0.12

Free Cash Flow Financials Revenue

Alfresa Holdings Corporation (ARHCF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ARHCF · free cash flow · updated Jun 8, 2026

Core FCF metrics

ARHCF · FCF · TTM · margin & CAGR

Free cash flow was $16.21B for FY2026 (fiscal year ending 2026-03-31), up 211.9% year-over-year The FCF margin was 0.5%.

FY2026 Free Cash Flow$16.21B▲ +211.9% YoY

Trailing 12M (TTM)$0trailing 4 quarters sum

FCF Margin0.5%$16.21B ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

ARHCF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2026Latest$38.81B(22.60B)$16.21B▲ +211.9%0.5%

FY2025$5.64B(20.13B)−$14.49B▼ 120.4%-0.5%

FY2024$86.38B(15.33B)$71.05B▲ +674.0%2.5%

FY2023$13.09B(25.46B)−$12.38B▼ 163.3%-0.5%

FY2022$36.55B(16.99B)$19.56B▲ +149.6%0.8%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

ARHCF · P/FCF · FCF yield · FCF per share

Alfresa Holdings Corporation (ARHCF) valuation ratios are currently unavailable — market cap, share count, or TTM data could not be retrieved from our data provider.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

Valuation ratios are unavailable — market cap, share count, or TTM data could not be retrieved. Individual metrics are shown where available.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2026 · 2026-03-31

Cash flow statement summary

ARHCF · cash flow statement · operating / investing / financing

For FY2026, Alfresa Holdings Corporation generated $38.81B in operating cash flow and spent 22.60B in capital expenditures, yielding $16.21B in free cash flow.

Operating Activities

+$38.81B

Cash from core business operations

2026-03-31

Investing Activities

−$8.78B

CapEx, acquisitions & investments

2026-03-31

Financing Activities

−$14.14B

Buybacks, dividends & debt

2026-03-31

FCF FormulaOperating CF ($38.81B) − |CapEx| (22.60B) = FCF ($16.21B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

ARHCF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Alfresa Holdings CorporationYOU

ARHCF

$16.21B+211.9%0.5%

82%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Alfresa Holdings Corporation (ARHCF) reported free cash flow of $16.21B for FY2026 (fiscal year ending 2026-03-31), up 211.9% year-over-year. The FCF margin was 0.5%.

Based on available data, Alfresa Holdings Corporation has maintained positive free cash flow for at least 11 fiscal year(s). FCF peaked at $75.55B in FY2013.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

ARHCF free cash flow · 8 questions

Alfresa Holdings Corporation free cash flow was $16.21B for FY2026, up 211.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $0.

ARHCF free cash flowARHCF FCFARHCF FCF 2026ARHCF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Alfresa Holdings Corporation · Alfresa Holdings Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026